Back to Journals » OncoTargets and Therapy » Volume 7

High expression of 23 kDa protein of augmenter of liver regeneration (ALR) in human hepatocellular carcinoma

Authors Yu H, Zhu M, Xiang D, Li J, Sheng J

Received 29 January 2014

Accepted for publication 7 April 2014

Published 2 June 2014 Volume 2014:7 Pages 887—893

DOI https://doi.org/10.2147/OTT.S61531

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2


Hai-Ying Yu, Man-Hua Zhu, Dai-Rong Xiang, Jun Li, Ji-Fang Sheng

State Key Laboratory of Infectious Disease and Department of Infectious Disease, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China

Background: Augmenter of liver regeneration (ALR) is an important polypeptide that participates in the process of liver regeneration. Two forms of ALR proteins are expressed in hepatocytes. Previous data have shown that ALR is essential for cell survival and has potential antimetastatic properties in hepatocellular carcinoma (HCC).
Aims: The study aimed to evaluate the expression levels of two forms of ALR proteins in HCC and their possible significance in HCC development.
Methods: Balb/c mouse monoclonal antibody against ALR protein was prepared in order to detect the ALR protein in HCC by Western blotting and immunohistochemistry. ALR mRNA expression levels were measured by real-time polymerase chain reaction in HCC tissues and compared to paracancerous liver tissues in 22 HCC patients.
Results: ALR mRNA expression in HCC liver tissues (1.51×106 copies/µL) was higher than in paracancerous tissues (1.04×104 copies/µL). ALR protein expression was also enhanced in HCC liver tissues. The enhanced ALR protein was shown to be 23 kDa by Western blotting. Immunohistochemical analysis showed that the 23 kDa ALR protein mainly existed in the hepatocyte cytosol.
Conclusion: The 23 kDa ALR protein was highly expressed in HCC and may play an important role in hepatocarcinogenesis.

Keywords: HCC, ALR mRNA, ALR protein


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]